Concepedia

Mohammad Alhadj Ali

MA

10

Publications

548

Citations

10

H-Index

2009

Active since

Affiliations

Cardiff University(Current)

Guy's and St Thomas' NHS Foundation Trust

University of Oxford

King's College London

Swansea University

Mohammad Alhadj Ali is an author at Cardiff University specializing in immunology, diabetes, and autoimmunity.

ORCID

Top concepts

Publications per year

2009–2023

10

Publications

10

Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes

Mohammad Alhadj Ali, Sefina Arif, Danijela Tatović et al. · Science Translational Medicine · 2017 · 211 citations · Full text

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 88 citations · Full text

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 74 citations · Full text

Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes

Danijela Tatović, Martina A. McAteer, J Barry et al. · Immunotherapy Advances · 2022 · 51 citations · Full text

, , +22

INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes

David B. Dunger, Sylvaine F. A. Bruggraber, Adrian Mander et al. · Trials · 2022 · 36 citations · Full text

Rows per page

1–5 of 10